JANX Latest Press Releases

-- November 9, 2026 --

Janux Therapeutics Announces Positive Initial Phase 1 Data for JANX011 in Healthy Volunteers, Supporting Planned Development in Patients with Autoimmune Disease Business Wire 8:30 AM

-- November 5, 2026 --

Janux Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights Business Wire 4:02 PM

-- November 2, 2026 --

Janux Therapeutics to Host Virtual Event Presenting Initial Phase 1 Clinical Data for JANX011 in Healthy Volunteers Business Wire 4:02 PM

-- September 14, 2026 --

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013 Business Wire 8:00 AM

-- August 6, 2026 --

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights Business Wire 4:02 PM

Market Data Delayed 15 Minutes